Spotlight Innovation Inc. (STLT) 1.0500 $STLT Spotlight

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Spotlight Innovation Inc. (STLT) 1.0500 $STLT

Spotlight Innovation Subsidiary Celtic Biotech Enters Into Research Agreement With Emory University
Marketwired - Mon Jul 06, 12:43PM CDT
Spotlight Innovation Inc. (OTCQB: STLT) announces today that its subsidiary Celtic Biotech has entered into a Research Agreement with Atlanta-based Emory University. The Phase I study will be designed and conducted by an Emory University research team with the specific aim of demonstrating that the cell penetrating peptide Crotamine can be made into a suitable radiopharmaceutical for imaging lung cancer tumors with positron emission tomography (PET) in a clinical setting.

Spotlight Innovation Retains DresnerAllenCaron as Its Investor Relations Firm
Marketwired - Thu Jun 18, 10:51AM CDT
Spotlight Innovation Inc. (OTCQB: STLT) announces today that it has retained DresnerAllenCaron as its investor relations firm. DresnerAllenCaron will design and execute investor relations programs to broaden awareness and visibility of Spotlight Innovation within the investment community, and the business and financial media.

Spotlight Innovation Completes Acquisition of Memcine Pharmaceuticals
Marketwired - Mon Jun 08, 9:45AM CDT
Spotlight Innovation Inc. (OTCQB: STLT) announces today that it completed the acquisition of a majority ownership in Memcine Pharmaceuticals Inc., located at the University of Iowa Research Park in Coralville, Iowa. Memcine Pharmaceuticals is developing its Immunoplex(TM) vaccine platform technology, which is designed to use the body's own naturally occurring targeting system to deliver vaccine components to immune cells and stimulate a robust response. Memcine Pharmaceuticals has a licensing agreement for its technologies with the University of Iowa.

Spotlight Innovation Subsidiary Celtic Biotech Retains the FreeMind Group to Identify, Prepare, and File for Research and Development Grant Opportunities
Marketwired - Tue Jun 02, 2:31PM CDT
Spotlight Innovation Inc. (OTCQB: STLT) announces today that FreeMind Group LLC has been retained by its subsidiary Celtic Biotech Iowa, Inc. to identify grant and contract funding opportunities from such agencies as the National Institutes of Health (NIH), Department of Defense (DoD) and Private Foundations, and to prepare and file grant applications for relevant opportunities. FreeMind Group's expertise in applying for grants and contracts extends throughout every government mechanism as well as private foundations open to funding the life sciences.

ImmunoClin Ltd. to Provide Contract Research Organization (CRO) Services for Crotoxin Phase I Part II Clinical Trials for Spotlight Innovation Subsidiary Celtic Biotech
Marketwired - Wed May 20, 11:40AM CDT
Spotlight Innovation Inc. (OTCQB: STLT) announces today that ImmunoClin Ltd. will act as its Contract Research Organization for its subsidiary Celtic Biotech Iowa, Inc.'s Part II of its Phase I clinical trial, Crotoxin in Patients with Advanced Cancer using an Intravenous Route of Administration. ImmunoClin Ltd. (a subsidiary of ImmunoClin Corporation, IMCL) will manage and coordinate all aspects of the clinical trial on behalf of Celtic Biotech including protocol preparation, monitoring, project management, and regulatory reporting.

Spotlight Innovation Becomes Member of Iowa Biotechnology Association
Marketwired - Tue May 12, 12:19PM CDT
Spotlight Innovation Inc. (OTCQB: STLT) announces today that it has become a member of the Iowa Biotechnology Association. The Association was founded to unify Iowa's bioscience industry, academic research institutions and economic development organizations, and to foster a strong business and research climate that attracts and retains bioscience talent, companies and funding.

Spotlight Innovation Closes $2.5 Million Financing
Marketwired - Tue Apr 28, 12:05PM CDT
Spotlight Innovation Inc. (the "Company" (OTCQB: STLT) announces that it has closed on an unsecured convertible promissory note in the gross principal amount of $2,500,000, exclusive of certain fees. The Note has a maturity date of March 27, 2020, and bears interest at the rate of Prime plus five percent (5%) during the first 36 months, increasing to an interest of Prime plus six percent (6%) for the remaining 24 months. The Note is convertible into shares of common stock of the Company at a price of $1.50 per share.

Spotlight Innovation Completes Private Placement Offering of $500,000
Marketwired - Tue Apr 21, 1:25PM CDT
Spotlight Innovation Inc. (OTCQB: STLT) announces the completion of a $500,000 private placement offering consisting of shares of common stock and warrants.

Spotlight Innovation Subsidiary Celtic Biotech Product EPISORB Available to Compounding Pharmacy Industry
Marketwired - Mon Apr 06, 12:44PM CDT
Spotlight Innovation Inc. (OTCQB: STLT) announces that the product EPISORB, developed by its subsidiary Celtic Biotech Iowa, Inc., has been registered with the U.S. Food and Drug Administration and has been incorporated into the Pharmacy Benefit Managers (PBM) database referenced by health insurance companies when reimbursing drugs. The product makes use of the attributes of cardiotoxin as a cell penetrating peptide and is intended for distribution through the compounding pharmacy industry.

Spotlight Innovation Enters Into Purchase Agreement With Memcine Pharmaceuticals
Marketwired - Tue Mar 17, 12:50PM CDT
Spotlight Innovation Inc. (OTCQB: STLT) announces that Spotlight Innovation Inc. entered into a Purchase Agreement with Coralville, Iowa-based Memcine Pharmaceuticals, Inc. Pursuant to the agreement, Spotlight Innovation will acquire a majority of the outstanding securities of Memcine Pharmaceuticals. The closing of the transaction is contingent upon several conditions including, but not limited to, completion of due diligence and entry into a shareholder agreement.

Spotlight Innovation Subsidiary Celtic Biotech Iowa Licenses Promising Therapy for Chronic Kidney Disease
Marketwired - Tue Mar 10, 2:46PM CDT
Spotlight Innovation Inc. (OTCQB: STLT) announces that its subsidiary Celtic Biotech Iowa, Inc., entered into an exclusive, world-wide (excluding China) license agreement to develop and market a patent-pending invention related to the treatment of acute and chronic nephropathy, Use of Cardiotoxin for the Treatment of Chronic Kidney Disease (CKD). Animal studies have shown that cardiotoxin has the ability to inhibit the inflammatory immune processes that damage the kidneys, can reduce the level of proteinurea, serum creatinine and urea in chronic neuropathy, and recover renal function and reduce renal injury.

Spotlight Innovation Subsidiary Celtic Biotech Iowa Granted Patent by the U.S. Patent and Trademark Office
Marketwired - Thu Jan 15, 1:22PM CST
Spotlight Innovation Inc. (OTCQB: STLT) announces that its subsidiary Celtic Biotech Iowa Inc. has been granted U.S. Patent entitled Crotoxin Administration for Cancer Treatment and Pain Relief. The invention relates to Crotoxin compositions for intravenous administration and methods of use of Crotoxin for the treatment of pain and/or for the treatment of neurologic and neuromuscular disorders.

Spotlight Innovation Signs Memorandum of Understanding (MOU) With Black Swan LLC
Marketwired - Tue Jan 06, 10:01AM CST
Spotlight Innovation Inc. (OTCQB: STLT) announces that it has entered into a Memorandum of Understanding with Black Swan LLC. Under the agreement, Black Swan will assist with activities such as identifying applicable government grants and loans, affecting beneficial changes to the legislative environment, advancing emerging technologies, identifying business partners, and developing new markets, particularly in the government sector.

Spotlight Innovation Announces Change of Transfer Agent
Marketwired - Tue Dec 16, 8:03AM CST
Spotlight Innovation Inc. (OTCQB: STLT) announces today that effective December 16, 2014, Spotlight Innovation is replacing Securities Transfer Corporation as the transfer agent and registrar of the securities of the Company.

Celtic Biotech Iowa Requests Reactivation and Transfer of National Drug Code Registration
Marketwired - Thu Dec 04, 9:30AM CST
Spotlight Innovation Inc. (OTCQB: STLT) announces that a request was submitted to the Center for Drug Evaluation and Research at the Food and Drug Administration to reactivate and transfer the Celtic Biotech (Ireland) National Drug Code (NDC) registration to Celtic Biotech Iowa Inc. in anticipation of the manufacture and commercialization of a proprietary transdermal delivery gel product. The novel gel formula, originally developed by scientists at Celtic Biotech to facilitate the topical delivery of its proprietary biologic analgesic and anti-inflammatory drugs, is designed to provide a convenient platform for the compounding pharmacy industry to prepare and effectively deliver topical pain medications.

Spotlight Innovation Signs Letter of Intent to Acquire Memcine Pharmaceuticals
Marketwired - Tue Oct 14, 3:51PM CDT
Spotlight Innovation Inc. (OTCQB: STLT) announced that it has signed a Letter of Intent to acquire majority ownership in Memcine Pharmaceuticals Inc., located at the University of Iowa Research Park in Coralville, Iowa. Memcine Pharmaceuticals is developing its Immunoplex(TM) vaccine platform technology, which is designed to use the body's own naturally occurring targeting system to deliver vaccine components to immune cells and stimulate a robust response.

Spotlight Innovation Retains Jerry Cirino as Special Advisor
ACCESSWIRE - Wed Oct 01, 1:21PM CDT
Image: http://www.accesswire.com/images/1075/STLT%20...o%20AW.jpg

Spotlight Innovation Retains Barwicki Investor Relations to Provide Global Investor Relations Program
ACCESSWIRE - Wed Sep 24, 1:04PM CDT
Image: http://www.accesswire.com/images/1075/STLT%20...o%20AW.jpg

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Google Search Data Sharing Faces a Privacy Reality Check

Updated Category News Views 33

Search queries are messy little confessions, and that is exactly why this case deserves more than a bureaucratic shrug. Woodway Assurance's independent assessment says Google's search-query data could be treated as anonymized for sharing under the Digital Markets Act, but only if the European Commission tightens parts of its July 2026 framework. That is not a clean bill...

Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today

Updated Category News Views 136

Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...

Continue Reading
PSEG Declares $0.67 Fourth-Quarter 2026 Cash Dividend

Updated Category News Views 112

A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 196

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
SecureSpace Plants a Fifth Flag in Miami Beach Storage

Updated Category News Views 111

A small box on Alton Road may carry outsized weight Miami Beach does not hand out cheap, easy real estate wins, which is why SecureSpace's opening at 633 Alton Road deserves a closer look than its modest footprint might suggest. The newly rebranded SecureSpace Miami Beach facility has 18,358 square feet of traditional storage and locker space spread across 536 units, plus...

Continue Reading
Dolby's Strong Quarter Meets a Flat 2027 Reality Check

Updated Category News Views 67

A licensing machine just coughed up a very good quarter, then told investors not to expect the engine to accelerate next year. That is the whole Dolby story in one uncomfortable breath. NYSE:DLB finished fiscal 2026 with fourth-quarter revenue of $374 million, up from $307 million a year earlier, while GAAP diluted earnings climbed to $0.86 from $0.51. Those are not...

Continue Reading
USFM's Disko Deal Waits on Greenland Until March 2027

Updated Category News Views 184

A missing Greenland signature has turned USFM’s grand Disko plan into a calendar problem. Nothing more dramatic has been disclosed, but nothing less consequential should be assumed either. March 31 replaces a deadline that already failed USFM executed its share purchase agreement with 80 Mile PLC and Disko Exploration Limited on May 8, 2026. The proposed bargain is...

Continue Reading
Hanmi Compressor Tests Vietnam Before Wider Expansion

Updated Category News Views 0

Compressed air is the sort of factory necessity nobody brags about until it fails, and that is precisely why Hanmi Compressor’s Vietnam plan deserves a sober look. The Daegu-based specialist is not arriving with a grand export victory lap. It is still building the front door: a website, a promotional video, and a process for finding Vietnamese manufacturers and...

Continue Reading
Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 99

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 108

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading

Top 5 Most Recently Viewed Articles

Rocket Companies Faces Turmoil Amid Zillow's Earnings Shock

Updated Category News Views 212

Rocket Companies Stock Falls After Market Reactions Rocket Companies Inc (NYSE: RKT) is experiencing a downward trend as investors reassess their positions in housing-related stocks. This comes in the wake of a notable sell-off linked to Zillow Group Inc's disappointing earnings report, alongside growing trepidation surrounding artificial intelligence's impact on the real...

Continue Reading
Understanding Dimensional Fund Advisors Ltd.'s Recent Disclosure Actions

Updated Category News Views 139

Introduction to Dimensional Fund Advisors Ltd. Dimensional Fund Advisors Ltd. stands as a prominent investment management firm that focuses on providing high-quality investment solutions. Known for its innovative strategies, the firm has made significant strides in the financial sector. Public Opening Position Disclosure The recent public opening position disclosure by...

Continue Reading
Challenges Ahead for Dunxin Financial Following Delisting

Updated Category News Views 154

Understanding Dunxin Financial's Delisting Process NEW YORK - NYSE American LLC has initiated delisting proceedings for Dunxin Financial Holdings Limited, identified by the ticker symbol DXF for its American depositary shares (ADSs). This move by NYSE Regulation follows a determination that Dunxin Financial's shares do not meet the necessary listing standards, mainly due...

Continue Reading
Pro Music Rights Gains Official Approval as PRO in US Market

Updated Category News Views 198

Pro Music Rights Officially Recognized as a Performing Rights Organization Music Licensing, Inc. (OTC: SONG) has recently celebrated a significant milestone with the official recognition of its wholly-owned subsidiary, Pro Music Rights (PMR), as a Performing Rights Organization (PRO). This acknowledgment, appearing in the Federal Register, elevates PMR’s status in the...

Continue Reading
Dentsply Sirona Welcomes Aldo M. Denti as CCO to Innovate Sales

Updated Category News Views 206

Dentsply Sirona Appoints New Chief Commercial Officer Dentsply Sirona Inc. (NASDAQ: XRAY) has made a significant move to strengthen its commercial strategies by appointing Aldo M. Denti as its new Executive Vice President and Chief Commercial Officer. This change signals a commitment to enhancing customer experience and streamlining operations within the company....

Continue Reading